44.46
price up icon1.05%   0.46
after-market After Hours: 44.42 -0.04 -0.09%
loading
Mirum Pharmaceuticals Inc stock is traded at $44.46, with a volume of 336.38K. It is up +1.05% in the last 24 hours and up +4.51% over the past month. Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
See More
Previous Close:
$44.00
Open:
$43.85
24h Volume:
336.38K
Relative Volume:
0.76
Market Cap:
$2.20B
Revenue:
$379.25M
Net Income/Loss:
$-77.34M
P/E Ratio:
-27.58
EPS:
-1.6122
Net Cash Flow:
$-27.87M
1W Performance:
+1.05%
1M Performance:
+4.51%
6M Performance:
-3.81%
1Y Performance:
+81.91%
1-Day Range:
Value
$43.30
$44.54
1-Week Range:
Value
$43.30
$44.65
52-Week Range:
Value
$23.83
$54.23

Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile

Name
Name
Mirum Pharmaceuticals Inc
Name
Phone
650-667-4085
Name
Address
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
Name
Employee
334
Name
Twitter
@mirumpharma
Name
Next Earnings Date
2024-11-04
Name
Latest SEC Filings
Name
MIRM's Discussions on Twitter

Compare MIRM with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
MIRM
Mirum Pharmaceuticals Inc
44.46 2.18B 379.25M -77.34M -27.87M -1.6122
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades

Date Action Analyst Rating Change
May-19-25 Resumed H.C. Wainwright Buy
Apr-17-24 Initiated Stifel Buy
Dec-18-23 Reiterated H.C. Wainwright Buy
Nov-20-23 Resumed JP Morgan Overweight
Nov-13-23 Initiated Morgan Stanley Overweight
Oct-24-23 Initiated Cantor Fitzgerald Overweight
Oct-17-23 Resumed Evercore ISI Outperform
Sep-20-23 Initiated JMP Securities Mkt Outperform
Sep-01-22 Initiated Citigroup Buy
Sep-20-21 Initiated JP Morgan Overweight
Aug-07-20 Upgrade Raymond James Outperform → Strong Buy
Aug-03-20 Initiated H.C. Wainwright Buy
Jul-31-20 Initiated Piper Sandler Overweight
Jun-25-20 Initiated Robert W. Baird Outperform
Aug-12-19 Initiated Citigroup Buy
Aug-12-19 Initiated Evercore ISI Outperform
Aug-12-19 Initiated Guggenheim Buy
Aug-12-19 Initiated ROTH Capital Buy
Aug-12-19 Initiated Raymond James Outperform
View All

Mirum Pharmaceuticals Inc Stock (MIRM) Latest News

pulisher
07:50 AM

Mirum pharmaceuticals raises 2025 revenue guidance to $435M-$450M driven by robust growth - MSN

07:50 AM
pulisher
May 30, 2025

Mirum Pharmaceuticals Holds 2025 Annual Stockholders Meeting - TipRanks

May 30, 2025
pulisher
May 30, 2025

Alagille Syndrome Treatment Market Detailed in New Research ReportMirum Pharmaceuticals, Albireo Pharma - openPR.com

May 30, 2025
pulisher
May 29, 2025

Two Sigma Investments LP Has $5.23 Million Stock Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

May 29, 2025
pulisher
May 28, 2025

Man Group plc Invests $289,000 in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

May 28, 2025
pulisher
May 26, 2025

Mirum Pharmaceuticals’ SWOT analysis: rare disease stock shows growth potential By Investing.com - Investing.com South Africa

May 26, 2025
pulisher
May 26, 2025

Mirum Pharmaceuticals’ SWOT analysis: rare disease stock shows growth potential - Investing.com Nigeria

May 26, 2025
pulisher
May 26, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Cuts Stock Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

May 26, 2025
pulisher
May 23, 2025

When the Price of (MIRM) Talks, People Listen - news.stocktradersdaily.com

May 23, 2025
pulisher
May 22, 2025

Mirum Pharmaceuticals (MIRM) – Research Analysts’ Weekly Ratings Changes - Defense World

May 22, 2025
pulisher
May 22, 2025

What is HC Wainwright’s Estimate for MIRM Q2 Earnings? - Defense World

May 22, 2025
pulisher
May 20, 2025

Mirum Pharmaceuticals Appoints Doug Sheehy, JD, as Chief Legal Officer - citybiz

May 20, 2025
pulisher
May 20, 2025

Comerica Bank Reduces Stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

May 20, 2025
pulisher
May 20, 2025

Mirum Pharmaceuticals (NASDAQ:MIRM) Given “Buy” Rating at HC Wainwright - Defense World

May 20, 2025
pulisher
May 19, 2025

Mirum Pharmaceuticals Names Doug Sheehy New Chief Legal Officer - Bloomberg Law News

May 19, 2025
pulisher
May 19, 2025

Mirum Pharmaceuticals (MIRM) Receives Buy Rating from HC Wainwri - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Mirum Pharmaceuticals (MIRM) Appoints New Chief Legal Officer | - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Mirum Pharmaceuticals (MIRM) Receives Buy Rating from HC Wainwright & Co. | MIRM Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Mirum Pharmaceuticals (MIRM) Receives Buy Rating with Promising Growth Potential | MIRM Stock News - GuruFocus

May 19, 2025
pulisher
May 17, 2025

Analysts Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Price Target at $60.64 - Defense World

May 17, 2025
pulisher
May 15, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q1 2025 Earnings Call Transcript - MSN

May 15, 2025
pulisher
May 15, 2025

Northern Trust Corp Acquires 32,059 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

May 15, 2025
pulisher
May 15, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Shares Sold by The Manufacturers Life Insurance Company - Defense World

May 15, 2025
pulisher
May 14, 2025

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences - Business Wire

May 14, 2025
pulisher
May 13, 2025

Mirum Pharmaceuticals (MIRM) Maintains Strong Buy Rating with Ra - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Mirum Pharmaceuticals (MIRM) Gets Price Target Boost to $77 | MI - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Trend Tracker for (MIRM) - news.stocktradersdaily.com

May 13, 2025
pulisher
May 12, 2025

FY2025 EPS Estimates for MIRM Raised by Cantor Fitzgerald - Defense World

May 12, 2025
pulisher
May 12, 2025

Leerink Partnrs Brokers Increase Earnings Estimates for MIRM - Defense World

May 12, 2025
pulisher
May 11, 2025

JMP Securities Increases Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target to $76.00 - Defense World

May 11, 2025
pulisher
May 09, 2025

Mirum Pharmaceuticals (MIRM) Price Target Raised Following Stron - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

May 09, 2025
pulisher
May 09, 2025

Beyond The Numbers: 4 Analysts Discuss Mirum Pharmaceuticals Stock - Benzinga

May 09, 2025
pulisher
May 09, 2025

Mirum Pharmaceuticals (MIRM) Maintains Market Outperform Rating with Higher Price Target | MIRM Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Mirum's Q1 Earnings Beat Estimates, 2025 Revenue View Raised - MSN

May 09, 2025
pulisher
May 09, 2025

Volixibat Data from Mirum’s VANTAGE PBC Study Showcased at EASL - Business Wire

May 09, 2025
pulisher
May 09, 2025

Mirum Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

JMP raises Mirum Pharmaceuticals stock target to $76 By Investing.com - Investing.com Canada

May 09, 2025
pulisher
May 09, 2025

Mirum Pharmaceuticals (MIRM) Price Target Raised Following Strong Revenue Outlook | MIRM Stock News - GuruFocus

May 09, 2025
pulisher
May 08, 2025

Evercore ISI lifts Mirum stock target to $76, maintains outperform By Investing.com - Investing.com Canada

May 08, 2025
pulisher
May 08, 2025

Evercore ISI lifts Mirum stock target to $76, maintains outperform - Investing.com

May 08, 2025
pulisher
May 08, 2025

Mirum Pharmaceuticals Reports Strong Q1 2025 Results - TipRanks

May 08, 2025
pulisher
May 08, 2025

Earnings call transcript: Mirum Pharmaceuticals beats Q1 2025 revenue forecasts - Investing.com

May 08, 2025
pulisher
May 07, 2025

Mirum Pharmaceuticals beats Q1 estimates, raises 2025 guidance; shares rise - Investing.com Nigeria

May 07, 2025
pulisher
May 07, 2025

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

Earnings Flash (MIRM) Mirum Pharmaceuticals Reports Q1 Revenue $111.6M, vs. FactSet Est of $98.4M - marketscreener.com

May 07, 2025

Mirum Pharmaceuticals Inc Stock (MIRM) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Cap:     |  Volume (24h):